TYK2 Inhibitor Shows Early Promise in Psoriatic Arthritis ...Middle East

More than half of patients assigned to TAK-279 achieved ACR20 at 12 weeks compared with 30% of patients assigned to placebo in a phase 2 clinical trial. Medscape Medical News

Hence then, the article about tyk2 inhibitor shows early promise in psoriatic arthritis was published today ( Tuesday 25/06/2024 - 12:29 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( TYK2 Inhibitor Shows Early Promise in Psoriatic Arthritis )

Also on site :

• As Colorado’s wildfire threat grows, Douglas County turns to biochar as ‘next level’ mitigation tool
• One of NYC’s Most Unexpected New Attractions Is Under Times Square
• 'Brady Bunch' Mom Florence Henderson Was in Talks for Wild Reboot Before Her Death